富科伊丹通过调节不同的细胞死亡来抑制前列腺癌的生长
M Tutuncu1, G Sanlav1, S Aktaş1
1Department of Basic Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey.
Nigerian journal of clinical practice
|July 31, 2024
概括
富科伊丹 (FUC) 显示为前列腺癌的抗癌药物,抑制瘤生长和增强多塞塔克塞尔 (DOC) 治疗. FUC显示出抗瘤原生作用,特别是在预防性应用中,这表明其在前列腺癌治疗中的潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 多西 (DOC) 是晚期前列腺癌的主要化疗,但其有限的生存益处需要新药.
- 富科伊丹 (FUC) 是棕藻中的硫酸多糖,具有有前途的抗癌特性.
- 这项研究研究了可伊丹单独或与多塞塔结合在前列腺癌模型中的抗瘤和预防作用.
研究的目的:
- 评估福科伊丹 (FUC) 作为独立治疗和与多塞 (DOC) 联合治疗前列腺癌的疗效.
- 分析FUC和DOC对各种细胞死亡方式的影响,包括细胞亡,亡和自.
- 评估FUC和DOC对氧化应激标志物和瘤生长 in vivo的影响.
主要方法:
- 在体内研究涉及六组大鼠:对照,FUC,DOC,FUC+DOC,预防性 (Pt) 和后预防性DOC (Pt-D).
- 免疫组织化学染色被用来评估与细胞死亡相关的蛋白质表达 (亡,亡,自标记物).
- 在瘤组织中测量了氧化应激标志物,包括脂质过氧化,谷氨过氧化酶 (GPX) 和谷氨 (GSH).
主要成果:
- 与对照组相比,富科伊丹和多塞塔克塞尔治疗显著诱导了亡,亡和自细胞死亡.
- 在富可伊丹和组合治疗组中,亡细胞死亡最为明显.
- 富科伊丹治疗减少了氧化应激标志物 (MDA,GPX,GSH) 和抑制了瘤生长,显示出抗瘤原生效应.
结论:
- 富科伊丹有效地抑制前列腺癌瘤的生长,无论是在时间上还是维度上,特别是当预防性地使用时.
- 富科伊丹单独或与多塞塔克塞尔结合,表现出显著的抗瘤原源作用.
- 富科伊丹是前列腺癌治疗的有前途的药物,有可能与多塞塔克塞尔一起作为预防或治疗药物.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K